Global health IT company focusing on personalized care and digital therapeutics. $443.5M funded. Provides remote patient monitoring and predictive analytics for clinical trials.
Vendor description
Enterprise remote monitoring and digital therapeutics platform
Remote patient monitoring,Digital therapeutics,Predictive analytics,DCT-enabling technology
- $443.5M funded
- Enterprise-grade platform
- Predictive analytics
- FDA-cleared algorithms
- Complex implementation
- Premium pricing
- Hardware dependency
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Pricing
$
Key facts
| HQ country | United States |
|---|---|
| Geography | Global |
| Service model | SaaS |
| Study phases | Phase I, Phase II, Phase III, Phase IV |
| Trial scale | Medium,Large,Global |
| Therapeutic areas | Cardiovascular, Respiratory, Oncology, Neurology, Rare diseases |
Related vendors
AncillareHome health / DCT (decentralized trials)
Care Access Research DirectHome health / DCT (decentralized trials)
Couch HealthHome health / DCT (decentralized trials)
Curavit Clinical ResearchHome health / DCT (decentralized trials)
Delve Health Clinical StudyPalHome health / DCT (decentralized trials)
Direct Patient LogisticsHome health / DCT (decentralized trials)
Editorial ranking
See how Biofourmis compares - best Home health / DCT (decentralized trials) vendors for clinical trials.